ALKEM LABORATORIES
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Alkem Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.62₹ -34.95
As on Nov 6, 2025, 4:01 PM IST
Alkem Laboratories Price Performance
Today's LowToday's High
₹5,584.50₹5,691.25
₹5,630.05
52 Weeks' Low52 Weeks' High
₹4,498.90₹5,960.75
₹5,630.05
Open Price
₹5,584.50
Prev. Close
₹5,665.00
Volume
3,029
Over the last 5 years, the share price of Alkem Laboratories has gained 15.41% CAGR. Over the past year, the corresponding return has been -0.76%.
Alkem Laboratories’s current P/E of 29.47x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.
Alkem Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alkem Laboratories | 1.70 | 2.56 | 14.50 | 10.92 | -0.76 | 20.43 | 15.41 |
| Sun Pharmaceutical Industries | -1.79 | 1.92 | 3.28 | -8.14 | -6.52 | 17.93 | 26.89 |
| Divi's Laboratories | 5.53 | 17.92 | 7.18 | 12.02 | 18.28 | 26.25 | 16.45 |
| Cipla | -5.11 | -0.91 | 0.05 | -2.79 | -6.32 | 9.87 | 13.57 |
| Torrent Pharmaceuticals | -0.88 | 1.22 | -0.58 | 8.68 | 11.99 | 28.56 | 22.33 |
| Dr. Reddy's Laboratories | -3.80 | -3.48 | -0.72 | 2.78 | -5.30 | 10.34 | 3.97 |
| Mankind Pharma | -5.54 | -5.82 | -11.76 | -4.42 | -14.93 | 17.48 | 10.15 |
| Zydus Lifesciences | -6.54 | -5.84 | -2.48 | 4.94 | -5.36 | 27.58 | 16.13 |
| Lupin | -0.04 | 0.93 | 4.97 | -6.29 | -10.28 | 40.20 | 15.88 |
| Aurobindo Pharma | 2.50 | 4.05 | 5.61 | -8.22 | -18.30 | 26.97 | 7.60 |
| Abbott India | -0.74 | -1.86 | -11.37 | -4.21 | 0.54 | 15.11 | 13.31 |
| Laurus Labs | 1.89 | 13.46 | 14.26 | 58.44 | 100.40 | 28.27 | 28.27 |
| Biocon | 3.07 | 10.87 | 3.34 | 14.63 | 21.97 | 11.44 | -1.40 |
| Glenmark Pharmaceuticals | -1.77 | -8.14 | -11.74 | 28.81 | 4.97 | 62.37 | 28.89 |
| GlaxoSmithKline Pharmaceuticals | -1.60 | -4.97 | -8.47 | -10.16 | 0.15 | 24.74 | 12.99 |
| Anthem Biosciences | -4.18 | -8.85 | -5.37 | -4.64 | -4.64 | -1.57 | -0.95 |
| Ipca Laboratories | 0.85 | -1.69 | -8.88 | -6.47 | -18.62 | 12.80 | 1.87 |
| Ajanta Pharma | 4.31 | 5.58 | -2.64 | -0.90 | -17.47 | 27.23 | 19.02 |
| Gland Pharma | 0.04 | -1.82 | -3.06 | 34.22 | 3.92 | 1.74 | 0.90 |
| Cohance Lifesciences | -7.97 | -16.69 | -24.69 | -37.01 | -45.71 | 18.05 | 17.31 |
Over the last one year, Alkem Laboratories has declined 0.76% compared to peers like Sun Pharmaceutical Industries (-6.52%), Divi's Laboratories (18.28%), Cipla (-6.32%). From a 5 year perspective, Alkem Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (26.89%) and Divi's Laboratories (16.45%).
Alkem Laboratories Financials
Alkem Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 5,493.78 | 5,548.85 |
| 10 | 5,523.27 | 5,532.41 |
| 20 | 5,507.78 | 5,513.42 |
| 50 | 5,450.98 | 5,425 |
| 100 | 5,193.87 | 5,306.38 |
| 200 | 5,082.48 | 5,229.28 |
Alkem Laboratories Share Holding Pattern
In the latest quarter, Alkem Laboratories saw a drop in promoter holding to 51.20%, while DII stake increased to 21.93%, FII holding rose to 9.47%, and public shareholding moved up to 17.39% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Alkem Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 14,99,220 | 1.2 | 813.33 | |
| 14,76,712 | 2.35 | 801.12 | |
| 12,98,455 | 2.88 | 704.41 | |
| 11,63,397 | 1.6 | 631.14 | |
| 10,04,007 | 1.15 | 544.67 | |
| 9,71,039 | 0.62 | 526.79 | |
| 7,48,010 | 2.12 | 405.8 | |
| 6,85,892 | 1.68 | 372.1 | |
| 5,36,946 | 2.02 | 291.29 | |
| 5,10,936 | 0.6 | 277.18 |
* Excluding Index & Arbitrage Funds
Alkem Laboratories Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Alkem Laboratories Options
Alkem Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 03, 2025, 9:47 PM IST | Alkem Laboratories - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order |
| Nov 03, 2025, 7:47 PM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) |
| Nov 03, 2025, 6:34 PM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 28, 2025, 9:41 PM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 28, 2025, 8:32 PM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Alkem Laboratories
Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8813.44 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressAlkem House, Senapati Bapat Marg, Mumbai Maharashtra 400013
- Contact
Management
- Mr. Basudeo N SinghExecutive Chairman
- Mr. Sandeep SinghManaging Director
- Mrs. Madhurima SinghExecutive Director
- Mr. Srinivas SinghExecutive Director
- Mr. Mritunjay Kumar SinghExecutive Director
- Mr. Sarvesh SinghExecutive Director
- Mr. Sujjain TalwarIndependent Director
- Mr. Narendra Kumar AnejaIndependent Director
- Mr. Rajeev KherIndependent Director
- Mr. Ranjal Laxmana ShenoyIndependent Director
- Ms. Neela BhattacherjeeIndependent Director
- Mr. Diwakar GuptaIndependent Director
FAQs on Alkem Laboratories Share Price
What is the share price of Alkem Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alkem Laboratories is ₹5,630.05 as on Nov 06, 2025.
What kind of stock is Alkem Laboratories?
The Alkem Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Alkem Laboratories?
The market cap of Alkem Laboratories is ₹67,315.69 Cr as on Nov 06, 2025.
What are today's High and Low prices of Alkem Laboratories?
Today’s highest and lowest price of Alkem Laboratories are ₹5,691.25 and ₹5,584.50.
What are the 52 Week High and 52 Week Low of Alkem Laboratories?
The 52-week high/low is the highest and lowest price at which Alkem Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Alkem Laboratories is ₹5,960.75 and 52-week low of Alkem Laboratories is ₹4,498.90 as on Nov 06, 2025.
How has the Alkem Laboratories performed historically in terms of returns?
The Alkem Laboratories has shown returns of -0.62% over the past day, 2.56% for the past month, 14.5% over 3 months, -0.76% over 1 year, 20.43% across 3 years, and 15.41% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Alkem Laboratories?
P/E ratio of and PB ratio of Alkem Laboratories are 29.47 and 5.62 on Nov 06, 2025. While the company gives a dividend yield of 0.80 per annum.
Alkem Laboratories News
✕
Market Pulse